What should patients and providers know about hormone replacement therapy (HRT)?Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, professor of pharmaceutical sciences at the University of Maryland School of Pharmacy, explains the risks, benefits, and what to consider with compounded hormone products.This research is supported by the U.S. Food and Drug Administration (FDA).Learn more about how UMB researchers are advancing science: https://vist.ly/45nuc#HormoneReplacementTherapy #BreakthroughsCantWaitUMB #UMBresearch #FDAResearch

Menopause symptoms like hot flashes and fatigue disrupt millions of women’s lives. University of Maryland, Baltimore researchers, supported by the U.S. Food and Drug Administration (FDA), are studying safer and more effective ways to manage symptoms—backed by science, not myths.Because breakthroughs can’t wait.#BreakthroughsCantWaitUMB #MenopauseResearch #WomensHealth #FDAResearch #FDAScience #HealthyAging

Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, is working to ensure drug delivery through the skin is safe and effective, and just the right dose — especially for menopausal medicines.Although transdermal patches help patients maintain consistency with drug therapies, it is critical to ensure patients receive just the right dose often over long periods of time.Learn more at https://www.umaryland.edu/breakthroughs#FDA #BreakthroughsCantWaitUMB #Menopause #transdermalpatch

Congress invests in global health research for one simple reason: diseases don’t stop at the ocean. By stopping outbreaks where they start, this UMB research protects Americans and strengthens global health security.Supported by the National Institutes of Health Fogarty International Center.#BreakthroughsCantWaitUMB #GlobalHealth #NIH #FogartyInternational #HealthSecurity #ResearchProtectsUs #Congress